Stanley M. Bergman
Chairman of the Board and Chief Executive Officer
pharmaceutical science
Henry Schein
Netherlands
Biography
Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500™ company and the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, with more than 21,000 Team Schein Members and operations or affiliates in 32 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2016, the Company's sales reached a record $11.6 billion. Henry Schein has been a Fortune World's Most Admired Company for 16 consecutive years.
Research Interest
Pharmacogenomics & Pharmacoproteomics
